About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
International Journal of Endocrine Oncology
›
top-articles
International Journal of Endocrine Oncology
0.4
(top 50%)
impact factor
152
(top 50%)
papers
547
(top 50%)
citations
11
(top 50%)
h
-index
0.4
(top 100%)
impact factor
161
all documents
586
doc citations
21
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Imaging in neuroendocrine tumors: an update for the clinician
International Journal of Endocrine Oncology
2015
95
2
Diagnosis of Zollinger–Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing
International Journal of Endocrine Oncology
2017
54
3
Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies
International Journal of Endocrine Oncology
2016
50
4
The ENETS/WHO grading system for neuroendocrine neoplasms of the gastroenteropancreatic system: a review of the current state, limitations and proposals for modifications
International Journal of Endocrine Oncology
2016
31
5
Exploring the tumors of multiple endocrine neoplasia type 1 in mouse models for basic and preclinical studies
International Journal of Endocrine Oncology
2014
23
6
11‐Deoxycortisol may be superior to cortisol in confirming a successful adrenal vein catheterization without cosyntropin: a pilot study
International Journal of Endocrine Oncology
2017
16
7
Molecular diagnostics and anaplastic thyroid carcinoma: the time has come to harvest the high hanging fruit
International Journal of Endocrine Oncology
2016
15
8
Current and future treatments for parathyroid carcinoma
International Journal of Endocrine Oncology
2018
14
9
68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor
International Journal of Endocrine Oncology
2018
14
10
Ovarian adult-type granulosa cell tumor: focusing on endocrine-based therapies
International Journal of Endocrine Oncology
2018
13
11
Emerging therapy for adrenocortical carcinoma
International Journal of Endocrine Oncology
2014
12
12
Treating medullary thyroid cancer in the age of targeted therapy
International Journal of Endocrine Oncology
2014
12
13
Treatment-emergent neuroendocrine prostate cancer: molecularly driven clinical guidelines
International Journal of Endocrine Oncology
2019
12
14
The role of 5-hydroxyindoleacetic acid in neuroendocrine tumors: the journey so far
International Journal of Endocrine Oncology
2019
11
15
Use of the gamma probe to identify multigland disease in primary hyperparathyroidism
International Journal of Endocrine Oncology
2016
10
16
Controversies in surgery for multiple endocrine neoplasia type 1-associated Zollinger–Ellison syndrome
International Journal of Endocrine Oncology
2015
9
17
Bilateral extramedullary adrenal plasmacytoma: case report and review of the literature
International Journal of Endocrine Oncology
2017
9
18
The recent European approval of lutetium (
177
Lu) oxodotreotide increases treatment options for gastroenteropancreatic neuroendocrine tumors
International Journal of Endocrine Oncology
2018
8
19
Protein kinase inhibitor therapy in advanced thyroid cancer: ethical challenges and potential solutions
International Journal of Endocrine Oncology
2014
7
20
Parathyroid cancer and the
CDC73
tumor suppressor gene
International Journal of Endocrine Oncology
2014
7
21
A patient with MEN1 typical features and MEN2-like features
International Journal of Endocrine Oncology
2016
7
22
Durable response to lenvatinib in progressive, therapy-refractory, metastatic paraganglioma
International Journal of Endocrine Oncology
2016
7
23
Tyrosine kinase inhibitors for the therapy of anaplastic thyroid cancer
International Journal of Endocrine Oncology
2015
6
24
Informed consent for low-risk thyroid cancer
International Journal of Endocrine Oncology
2016
6
25
Circulating tumor markers in patients with neuroendocrine tumors – a clinical perspective
International Journal of Endocrine Oncology
2015
5
26
A review on management discussions of small intestinal neuroendocrine tumors ‘midgut carcinoids’
International Journal of Endocrine Oncology
2015
5
27
Laser ablation with or without chemoembolization for unresectable neuroendocrine liver metastases: a pilot study
International Journal of Endocrine Oncology
2016
5
28
Adrenocortical carcinoma: modern management and evolving treatment strategies
International Journal of Endocrine Oncology
2016
5
29
The surgical management of primary hyperparathyroidism: an updated review
International Journal of Endocrine Oncology
2018
5
30
Do glycine-extended hormone precursors have clinical significance?
International Journal of Endocrine Oncology
2014
4
31
Role of molecular diagnostic markers in the management of indeterminate and suspicious thyroid nodules
International Journal of Endocrine Oncology
2014
4
32
A pathologist's view: molecular profiles for diagnosing pheochromocytomas and paragangliomas
International Journal of Endocrine Oncology
2015
4
33
Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors: current state and future perspectives
International Journal of Endocrine Oncology
2015
4
34
Update on management of midgut neuroendocrine tumors
International Journal of Endocrine Oncology
2016
4
35
Exceptional response to vemurafenib and cobimetinib in anaplastic thyroid cancer 40 years after treatment for papillary thyroid cancer
International Journal of Endocrine Oncology
2017
4
36
Novel therapies against aggressive differentiated thyroid carcinomas
International Journal of Endocrine Oncology
2018
4
37
Neoadjuvant use of lenvatinib in locally advanced papillary thyroid carcinoma involving critical vessels
International Journal of Endocrine Oncology
2020
4
38
Central compartment lymph node dissection for differentiated thyroid cancer: review of the literature
International Journal of Endocrine Oncology
2014
3
39
Central neck dissection in the treatment of well-differentiated thyroid cancer
International Journal of Endocrine Oncology
2015
3
40
Value-based healthcare: implications for thyroid cancer
International Journal of Endocrine Oncology
2016
3
41
Mahvash disease: an autosomal recessive hereditary pancreatic neuroendocrine tumor syndrome
International Journal of Endocrine Oncology
2016
3
42
Signaling pathways in medullary thyroid carcinoma: therapeutic implications
International Journal of Endocrine Oncology
2016
3
43
Does current thyroid cancer staging accurately reflect the impact of lymph node metastases on survival in younger patients?
International Journal of Endocrine Oncology
2016
3
44
The long goodbye to glycine-extended peptide hormones
International Journal of Endocrine Oncology
2017
3
45
Epigenetic dysregulation in pituitary tumors
International Journal of Endocrine Oncology
2019
3
46
Could targeting hormone receptors be an effective strategy in management of adrenal hyperplasia?
International Journal of Endocrine Oncology
2014
2
47
Robotic thyroidectomy: facelift approach
International Journal of Endocrine Oncology
2014
2
48
Oncolytic virotherapy for thyroid cancer: will it translate to the clinic?
International Journal of Endocrine Oncology
2015
2
49
Models of pheochromocytoma: what's on the horizon?
International Journal of Endocrine Oncology
2015
2
50
The challenge of managing adrenocortical carcinoma: two case studies
International Journal of Endocrine Oncology
2015
2
site/software ©
exaly
; All materials licenced under
CC by-SA
.